Last reviewed · How we verify
endoscopic ultrasonograhy guided chemptherapy injection
endoscopic ultrasonograhy guided chemptherapy injection is a Small molecule drug developed by Assiut University. It is currently in Phase 2 development.
At a glance
| Generic name | endoscopic ultrasonograhy guided chemptherapy injection |
|---|---|
| Sponsor | Assiut University |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer. (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- endoscopic ultrasonograhy guided chemptherapy injection CI brief — competitive landscape report
- endoscopic ultrasonograhy guided chemptherapy injection updates RSS · CI watch RSS
- Assiut University portfolio CI
Frequently asked questions about endoscopic ultrasonograhy guided chemptherapy injection
What is endoscopic ultrasonograhy guided chemptherapy injection?
endoscopic ultrasonograhy guided chemptherapy injection is a Small molecule drug developed by Assiut University.
Who makes endoscopic ultrasonograhy guided chemptherapy injection?
endoscopic ultrasonograhy guided chemptherapy injection is developed by Assiut University (see full Assiut University pipeline at /company/assiut-university).
What development phase is endoscopic ultrasonograhy guided chemptherapy injection in?
endoscopic ultrasonograhy guided chemptherapy injection is in Phase 2.